Dan Williams discusses SynaptixBio’s history, status, and aspirations in a major interview for leading US biotech podcast RAREcastDr Dan WilliamsJan 91 min readYou can listen to Dan Williams from SynaptixBio in the RAREcast podcast here.
SynaptixBio reaches hugely significant milestone with selection of candidate drug for clinical trials
Comments